Compare MobilEye Global Inc (MBLY) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MobilEye Global Inc vs Oscar Health Inc — how do they compare? MobilEye Global Inc trades at $7.1 (market cap $6.00B), while Oscar Health Inc trades at $33.37 (market cap $10.22B). The key difference: Oscar Health Inc is the larger of the two by market cap, and Oscar Health Inc is trading nearer its 52-week high, MobilEye Global Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold MobilEye Global Inc for 15 Days and Oscar Health Inc for 15 Days on average.
| MBLY | OSCR | |
|---|---|---|
Market Cap | $6.00B | $10.22B |
Volume | 7,007,849 | 4,123,394 |
Sector | Consumer Cyclical | Health |
52-Week High | $15.42 | $33.81 |
52-Week Low | $6.56 | $10.85 |
Typical Hold Time | 15 Days | 15 Days |
Enterprise Value | $4.56B | $6.57B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Mobileye Global (MBLY) trades at $7.06, down 1.26% on the day, with a bearish technical signal and negative profitability metrics including a net income margin of -201.49% for 2026. Recent earnings show mixed results, with Q2 2026 beating expectations but Q4 2025 missing. The company maintains strong cash flow from operations of $602 million in 2025, though 2026 saw a net cash outflow of $393 million. Analyst consensus is a 'Buy' with a $10.83 price target, but technical indicators and recent news highlight volatility and execution risks in the autonomous driving sector.
The outlook for MBLY is cautious due to persistent losses and competitive pressures, yet the stock trades below book value (P/B 0.73), offering potential upside if operational improvements materialize. Key risks include high cash burn, reliance on ADAS market growth, and macroeconomic headwinds. Investors should weigh the bullish analyst targets against fundamental weaknesses and technical bearishness for a balanced view.
OSCR trades at $33.10, up 0.58% with a bullish technical signal and strong institutional support. Recent earnings show volatility with Q1 and Q2 2026 beats but a Q4 2025 miss. Revenue grew from $11.7B in 2025 to $15.3B in 2026, with net income turning positive at $551M. Analyst consensus is mixed with 30.77% buy ratings and a $34.00 price target, slightly above current levels.
The outlook is cautiously optimistic with strong revenue growth and profitability improvements, though risks include medical cost pressures and competitive ACA market dynamics. Upside potential exists if margin expansion continues, but investors should monitor execution against guidance and healthcare sector headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About MobilEye Global Inc
Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.
Read more on MBLY →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
